Development of the opioid self-management scale for advanced Cancer patients with pain and examination of its validity and reliability

Abstract Background Approximately 60% of outpatients with advanced cancer experience pain; therefore, self-management of opioid use is important for appropriate pain relief. To date, no studies have clearly described the concept of opioid self-management or assessed the factors involved, including t...

Full description

Bibliographic Details
Main Authors: Shiori Yoshida, Fumiko Sato, Keita Tagami, Rie Sasaki, Chikako Takahashi, Konosuke Sasaki, Shin Takahashi
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Palliative Care
Subjects:
Online Access:https://doi.org/10.1186/s12904-022-00987-4
_version_ 1811251458410020864
author Shiori Yoshida
Fumiko Sato
Keita Tagami
Rie Sasaki
Chikako Takahashi
Konosuke Sasaki
Shin Takahashi
author_facet Shiori Yoshida
Fumiko Sato
Keita Tagami
Rie Sasaki
Chikako Takahashi
Konosuke Sasaki
Shin Takahashi
author_sort Shiori Yoshida
collection DOAJ
description Abstract Background Approximately 60% of outpatients with advanced cancer experience pain; therefore, self-management of opioid use is important for appropriate pain relief. To date, no studies have clearly described the concept of opioid self-management or assessed the factors involved, including the improvement of self-management abilities. This study developed, and evaluated the validity and reliability of an opioid self-management scale for advanced cancer patients with pain (OSSA). Opioid self-management in advanced cancer patients with pain was defined as the management of opioid medication performed by patients with advanced cancer to relieve cancer pain on their own. Methods Three phases were required for validation and reliability of the OSSA: 1) testing content validity, 2) testing face validity, and 3) testing construct validity, concurrent validity and reliability. Results After a three-phase process, the OSSA consisted of 33 items on six subscales. The structural equation modeling was such that the χ2 value was 709.8 (p < 0.001, df = 467), goodness-of-fit index was 0.78, adjusted goodness-of-fit index was 0.73, root mean squares of approximation was 0.063, and comparative fit index was 0.92. The Pearson correlation coefficients between the total OSSA score and the 24-hour average pain or pain relief over 24 hours were − 0.21 (p < 0.05) and 0.26 (p < 0.01), respectively. Cronbach’s α was 0.93. The intraclass correlation coefficient range was 0.59–0.90. Conclusion The findings of this study show that the OSSA has acceptable validity and reliability, and that better self-management leads to greater pain relief. The OSSA can be considered effective for use in research, but shortened version should be prepared for realistic and practical clinical use.
first_indexed 2024-04-12T16:20:45Z
format Article
id doaj.art-381614f0b1214e3e97cdcf972fe8f1bf
institution Directory Open Access Journal
issn 1472-684X
language English
last_indexed 2024-04-12T16:20:45Z
publishDate 2022-06-01
publisher BMC
record_format Article
series BMC Palliative Care
spelling doaj.art-381614f0b1214e3e97cdcf972fe8f1bf2022-12-22T03:25:34ZengBMCBMC Palliative Care1472-684X2022-06-0121111310.1186/s12904-022-00987-4Development of the opioid self-management scale for advanced Cancer patients with pain and examination of its validity and reliabilityShiori Yoshida0Fumiko Sato1Keita Tagami2Rie Sasaki3Chikako Takahashi4Konosuke Sasaki5Shin Takahashi6Department of Oncology Nursing, Health Sciences, Tohoku University Graduate School of MedicineSchool of Nursing, Fukushima Medical UniversityDepartment of Palliative Medicine, Tohoku University Graduate School of MedicineDepartment of Nursing, Miyagi Cancer CenterDepartment of Nursing, Tohoku University HospitalDepartment of Oncology Nursing, Health Sciences, Tohoku University Graduate School of MedicineDepartment of Medical Oncology, Tohoku University HospitalAbstract Background Approximately 60% of outpatients with advanced cancer experience pain; therefore, self-management of opioid use is important for appropriate pain relief. To date, no studies have clearly described the concept of opioid self-management or assessed the factors involved, including the improvement of self-management abilities. This study developed, and evaluated the validity and reliability of an opioid self-management scale for advanced cancer patients with pain (OSSA). Opioid self-management in advanced cancer patients with pain was defined as the management of opioid medication performed by patients with advanced cancer to relieve cancer pain on their own. Methods Three phases were required for validation and reliability of the OSSA: 1) testing content validity, 2) testing face validity, and 3) testing construct validity, concurrent validity and reliability. Results After a three-phase process, the OSSA consisted of 33 items on six subscales. The structural equation modeling was such that the χ2 value was 709.8 (p < 0.001, df = 467), goodness-of-fit index was 0.78, adjusted goodness-of-fit index was 0.73, root mean squares of approximation was 0.063, and comparative fit index was 0.92. The Pearson correlation coefficients between the total OSSA score and the 24-hour average pain or pain relief over 24 hours were − 0.21 (p < 0.05) and 0.26 (p < 0.01), respectively. Cronbach’s α was 0.93. The intraclass correlation coefficient range was 0.59–0.90. Conclusion The findings of this study show that the OSSA has acceptable validity and reliability, and that better self-management leads to greater pain relief. The OSSA can be considered effective for use in research, but shortened version should be prepared for realistic and practical clinical use.https://doi.org/10.1186/s12904-022-00987-4Advanced cancerCancer painOpioid medicationSelf-management
spellingShingle Shiori Yoshida
Fumiko Sato
Keita Tagami
Rie Sasaki
Chikako Takahashi
Konosuke Sasaki
Shin Takahashi
Development of the opioid self-management scale for advanced Cancer patients with pain and examination of its validity and reliability
BMC Palliative Care
Advanced cancer
Cancer pain
Opioid medication
Self-management
title Development of the opioid self-management scale for advanced Cancer patients with pain and examination of its validity and reliability
title_full Development of the opioid self-management scale for advanced Cancer patients with pain and examination of its validity and reliability
title_fullStr Development of the opioid self-management scale for advanced Cancer patients with pain and examination of its validity and reliability
title_full_unstemmed Development of the opioid self-management scale for advanced Cancer patients with pain and examination of its validity and reliability
title_short Development of the opioid self-management scale for advanced Cancer patients with pain and examination of its validity and reliability
title_sort development of the opioid self management scale for advanced cancer patients with pain and examination of its validity and reliability
topic Advanced cancer
Cancer pain
Opioid medication
Self-management
url https://doi.org/10.1186/s12904-022-00987-4
work_keys_str_mv AT shioriyoshida developmentoftheopioidselfmanagementscaleforadvancedcancerpatientswithpainandexaminationofitsvalidityandreliability
AT fumikosato developmentoftheopioidselfmanagementscaleforadvancedcancerpatientswithpainandexaminationofitsvalidityandreliability
AT keitatagami developmentoftheopioidselfmanagementscaleforadvancedcancerpatientswithpainandexaminationofitsvalidityandreliability
AT riesasaki developmentoftheopioidselfmanagementscaleforadvancedcancerpatientswithpainandexaminationofitsvalidityandreliability
AT chikakotakahashi developmentoftheopioidselfmanagementscaleforadvancedcancerpatientswithpainandexaminationofitsvalidityandreliability
AT konosukesasaki developmentoftheopioidselfmanagementscaleforadvancedcancerpatientswithpainandexaminationofitsvalidityandreliability
AT shintakahashi developmentoftheopioidselfmanagementscaleforadvancedcancerpatientswithpainandexaminationofitsvalidityandreliability